Datopotamab deruxtecan now #FDA approved off #TROPIONBreast01: #DatoDXd Vs Chemo post 1-2L HR+ mBC
- ⏰ to 1st Rx: 8.2 vs 5mos (favoring Dato)
- ⬆️ PFS 6.9mos vs 4.5 mos
- Better AE + QoL favoring DatoDXd
- AEs: Fatigue, infusion reactions, stomatitis
#bcsm #OncSky #MedSky
- ⏰ to 1st Rx: 8.2 vs 5mos (favoring Dato)
- ⬆️ PFS 6.9mos vs 4.5 mos
- Better AE + QoL favoring DatoDXd
- AEs: Fatigue, infusion reactions, stomatitis
#bcsm #OncSky #MedSky
January 17, 2025 at 6:36 PM
Everybody can reply
2 reposts
7 likes
@benlevylungdoc.bsky.social from Johns Hopkins reports results of chemo+datoDXD with biomarker data #ASCO25
June 1, 2025 at 1:25 PM
Everybody can reply
1 reposts
4 likes
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis academic.oup.com/oncolo/artic...
#SuppOnc #DatoDXd @hoperugo.bsky.social
#SuppOnc #DatoDXd @hoperugo.bsky.social
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis
Abstract. Oral mucositis/stomatitis (hereafter stomatitis) is a common dose-limiting toxicity seen with various classes of cancer treatment. Symptoms assoc
academic.oup.com
April 5, 2025 at 1:04 AM
Everybody can reply
2 reposts
4 likes
VJ Oncology - Paolo Tarantino on Investigating Dato-DXd in HER2- Breast Cancer Brain Metastases
@ptarantinomd.bsky.social
oncodaily.com/voices/dato-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DatoDXd #BreastCancer #mBC
@ptarantinomd.bsky.social
oncodaily.com/voices/dato-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DatoDXd #BreastCancer #mBC
Paolo Tarantino on Investigating Dato-DXd in HER2- Breast Cancer Brain Metastases - VJ Oncology - OncoDaily
Paolo Tarantino on Investigating Dato-DXd in HER2- Breast Cancer Brain Metastases - VJ Oncology / Breast Cancer, cancer, Dana-Farber Cancer Institute,
oncodaily.com
August 21, 2025 at 12:26 AM
Everybody can reply
5 likes